Rock Springs Capital Management as of March 31, 2015
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 105 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medtronic (MDT) | 4.2 | $45M | 572k | 77.99 | |
| Abbvie (ABBV) | 3.3 | $35M | 600k | 58.54 | |
| McKesson Corporation (MCK) | 3.1 | $34M | 149k | 226.20 | |
| Actavis | 3.1 | $34M | 113k | 297.62 | |
| Hca Holdings (HCA) | 3.0 | $32M | 423k | 75.23 | |
| Valeant Pharmaceuticals Int | 2.9 | $31M | 155k | 198.62 | |
| Pfizer (PFE) | 2.5 | $26M | 760k | 34.79 | |
| Amgen (AMGN) | 2.5 | $26M | 164k | 159.85 | |
| Acadia Healthcare (ACHC) | 2.4 | $26M | 363k | 71.60 | |
| Gilead Sciences (GILD) | 2.3 | $25M | 255k | 98.13 | |
| Pharmacyclics | 2.1 | $23M | 88k | 255.95 | |
| Celgene Corporation | 2.1 | $22M | 195k | 115.28 | |
| Envision Healthcare Hlds | 2.0 | $22M | 570k | 38.35 | |
| Thoratec Corporation | 2.0 | $22M | 515k | 41.89 | |
| Humana (HUM) | 1.8 | $19M | 108k | 178.02 | |
| Alexion Pharmaceuticals | 1.8 | $19M | 108k | 173.30 | |
| Team Health Holdings | 1.7 | $18M | 311k | 58.51 | |
| Tornier Nv | 1.6 | $17M | 660k | 26.22 | |
| CVS Caremark Corporation (CVS) | 1.6 | $17M | 164k | 103.21 | |
| Retrophin | 1.6 | $17M | 700k | 23.96 | |
| Eli Lilly & Co. (LLY) | 1.6 | $17M | 230k | 72.65 | |
| Aetna | 1.6 | $17M | 157k | 106.53 | |
| Radius Health | 1.5 | $17M | 400k | 41.16 | |
| CIGNA Corporation | 1.5 | $16M | 122k | 129.44 | |
| Biogen Idec (BIIB) | 1.5 | $16M | 37k | 422.24 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $15M | 375k | 39.71 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $13M | 100k | 134.34 | |
| Orexigen Therapeutics | 1.1 | $12M | 1.6M | 7.83 | |
| Tesaro | 1.1 | $12M | 210k | 57.40 | |
| Intuitive Surgical (ISRG) | 1.1 | $11M | 23k | 505.02 | |
| Inovalon Holdings Inc Cl A | 1.1 | $11M | 375k | 30.21 | |
| Receptos | 1.0 | $11M | 65k | 164.89 | |
| Incyte Corporation (INCY) | 1.0 | $10M | 113k | 91.66 | |
| Stericycle (SRCL) | 1.0 | $10M | 74k | 140.44 | |
| Cooper Companies | 0.9 | $10M | 54k | 187.43 | |
| Intercept Pharmaceuticals In | 0.9 | $10M | 36k | 282.03 | |
| Healthsouth | 0.9 | $9.8M | 220k | 44.36 | |
| Laboratory Corp. of America Holdings | 0.9 | $9.5M | 75k | 126.09 | |
| RTI Biologics | 0.9 | $9.2M | 1.9M | 4.94 | |
| HeartWare International | 0.9 | $9.2M | 105k | 87.77 | |
| Prothena (PRTA) | 0.8 | $9.1M | 238k | 38.14 | |
| Danaher Corporation (DHR) | 0.8 | $9.0M | 106k | 84.90 | |
| Medicines Company | 0.8 | $8.4M | 300k | 28.02 | |
| Flamel Technologies | 0.8 | $8.3M | 460k | 17.98 | |
| Pra Health Sciences | 0.8 | $8.2M | 285k | 28.84 | |
| Health Care SPDR (XLV) | 0.8 | $8.0M | 110k | 72.50 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $8.0M | 68k | 117.97 | |
| Perrigo Company (PRGO) | 0.7 | $7.8M | 47k | 165.55 | |
| Novadaq Technologies | 0.7 | $7.7M | 475k | 16.24 | |
| Insmed (INSM) | 0.7 | $7.6M | 365k | 20.80 | |
| Relypsa | 0.7 | $7.4M | 205k | 36.07 | |
| Juno Therapeutics | 0.7 | $7.4M | 122k | 60.66 | |
| DaVita (DVA) | 0.7 | $7.3M | 90k | 81.28 | |
| Advaxis | 0.7 | $7.1M | 490k | 14.44 | |
| Zs Pharma | 0.6 | $6.6M | 158k | 42.08 | |
| WuXi PharmaTech | 0.6 | $6.5M | 168k | 38.78 | |
| Theravance Biopharma (TBPH) | 0.6 | $6.5M | 374k | 17.35 | |
| Gw Pharmaceuticals Plc ads | 0.6 | $6.4M | 70k | 91.13 | |
| Steris Corporation | 0.6 | $6.2M | 88k | 70.27 | |
| Connecture | 0.6 | $6.2M | 600k | 10.35 | |
| Coherus Biosciences (CHRS) | 0.6 | $6.1M | 199k | 30.58 | |
| Novavax | 0.6 | $6.0M | 730k | 8.27 | |
| Tandem Diabetes Care | 0.6 | $6.0M | 476k | 12.62 | |
| Achillion Pharmaceuticals | 0.6 | $5.9M | 600k | 9.86 | |
| Puma Biotechnology (PBYI) | 0.5 | $5.7M | 24k | 236.12 | |
| Kythera Biopharmaceuticals I | 0.5 | $5.8M | 115k | 50.15 | |
| Epizyme | 0.5 | $5.8M | 307k | 18.78 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $5.7M | 92k | 62.09 | |
| WellCare Health Plans | 0.5 | $5.5M | 60k | 91.47 | |
| Cardiome Pharma | 0.5 | $5.2M | 565k | 9.26 | |
| Actavis Plc Conv Pfd Ser A pfd conv ser a | 0.5 | $5.2M | 5.0k | 1030.00 | |
| Cerulean Pharma | 0.5 | $4.9M | 540k | 9.01 | |
| Fibrogen (FGEN) | 0.4 | $4.7M | 151k | 31.38 | |
| Aerie Pharmaceuticals | 0.4 | $4.6M | 146k | 31.34 | |
| Regeneron Pharmaceuticals (REGN) | 0.4 | $4.5M | 10k | 451.50 | |
| Illumina (ILMN) | 0.4 | $4.5M | 24k | 185.62 | |
| Pacira Pharmaceuticals (PCRX) | 0.4 | $4.5M | 51k | 88.85 | |
| Jazz Pharmaceuticals (JAZZ) | 0.4 | $4.5M | 26k | 172.81 | |
| Cerner Corporation | 0.4 | $4.4M | 60k | 73.27 | |
| CHINA CORD Blood Corp | 0.4 | $4.2M | 830k | 5.11 | |
| Kite Pharma | 0.4 | $4.1M | 72k | 57.69 | |
| Assembly Biosciences | 0.4 | $4.2M | 318k | 13.24 | |
| BioMarin Pharmaceutical (BMRN) | 0.4 | $4.1M | 33k | 124.62 | |
| Castlight Health | 0.4 | $4.1M | 525k | 7.76 | |
| Tetraphase Pharmaceuticals | 0.3 | $3.8M | 103k | 36.64 | |
| Macrogenics (MGNX) | 0.3 | $3.7M | 117k | 31.37 | |
| Five Prime Therapeutics | 0.3 | $3.1M | 136k | 22.85 | |
| Infinity Pharmaceuticals (INFIQ) | 0.3 | $3.0M | 215k | 13.98 | |
| Bluebird Bio (BLUE) | 0.3 | $3.0M | 25k | 120.76 | |
| Avalanche Biotechnologies In | 0.3 | $2.9M | 71k | 40.52 | |
| Benefitfocus | 0.3 | $2.8M | 75k | 36.79 | |
| Spark Therapeutics | 0.2 | $2.6M | 33k | 77.51 | |
| Cellectis S A (CLLS) | 0.2 | $2.6M | 75k | 34.59 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $2.5M | 41k | 60.84 | |
| XenoPort | 0.2 | $2.2M | 310k | 7.12 | |
| Invitae (NVTAQ) | 0.2 | $2.1M | 125k | 16.76 | |
| Trivascular Technologies | 0.2 | $2.1M | 198k | 10.49 | |
| Anthera Pharmaceutcls | 0.2 | $1.9M | 425k | 4.47 | |
| Kindred Biosciences | 0.2 | $2.0M | 275k | 7.14 | |
| Raptor Pharmaceutical | 0.2 | $1.7M | 155k | 10.87 | |
| EnteroMedics | 0.1 | $747k | 812k | 0.92 | |
| Roka Bioscience | 0.1 | $800k | 250k | 3.20 | |
| Dermira | 0.1 | $649k | 42k | 15.35 | |
| Ascendis Pharma A S (ASND) | 0.1 | $617k | 36k | 17.36 | |
| Heron Therapeutics (HRTX) | 0.0 | $473k | 33k | 14.55 |
